Aligos Therapeutics Stock Forecast

Buy or Hold candidate since Jul 02, 2026 Gain 13.77%

The Aligos Therapeutics Inc. stock price fell by -3.93% on the last day (Monday, 13th Jul 2026) from $6.62 to $6.36. During the last trading day the stock fluctuated 6.98% from a day low at $6.16 to a day high of $6.59. The price has risen in 6 of the last 10 days and is up by 14.18% over the past 2 weeks. Volume has increased on the last day by 58 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 168 thousand shares were bought and sold for approximately $1.07 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.07% during the next 3 months and, with a 90% probability hold a price between $3.80 and $6.45 at the end of this 3-month period.

ALGS Signals & Forecast

The Aligos Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.29 and $5.59. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 29.53%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Aligos Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Aligos Therapeutics Inc. stock

Aligos Therapeutics Inc. finds support from accumulated volume at $6.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.430 between high and low, or 6.98%. For the last week, the stock has had daily average volatility of 10.75%.

Our recommended stop-loss: $6.18 (-2.76%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 24 days ago.)

Trading Expectations (ALGS) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Aligos Therapeutics Inc. to open at $6.37, and during the day (based on 14 day Average True Range), to move between $6.12 and $6.60, which gives a possible trading interval of +/-$0.478 (+/-7.82%) up or down from last closing price. If Aligos Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $6.44 (1.26%) than the support at $6.09 (4.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aligos Therapeutics Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.827 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $6.37 ( 0.157%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk